Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.
How can Australia fix the issue of COVID vaccine maldistribution? Undersupply has driven hundreds of general practices to quit the vaccine rollout as thousands of doses sit unused at mass vaccination clinics.
Potential COVID treatment reduces viral count in mice lungs by 99.9% And experts believe this form of medicine will translate to similar outcomes in humans, making it a ‘viable therapy’ for COVID-19.
‘Disconnect’ between health and disability behind slow vaccine rollout GPs have reportedly been underutilised in attempts to carry out perhaps the most complicated part of the national COVID vaccination program.
European regulator says Pfizer can be stored in fridges for 31 days Should the TGA follow suit, it could pave the way for greater general practice involvement in the COVID vaccine rollout.
No obvious barriers for GP involvement in potential Moderna rollout Existing infrastructure should allow general practices to take part in the administration of up to 25 million doses of the mRNA COVID vaccine once it is approved for use in Australia.
‘Nervous’ wait for aerosol guidelines following another HQ leak Consensus guidelines on face mask and eye protection against COVID are currently with ICEG for review.
Evidence suggests AstraZeneca and Pfizer are equally effective Experts say the research is reassuring, and indicates that both COVID vaccines offer a pathway to Australia reaching a high level of immunity.
National vaccine program key driver in reduced COVID cases: Study Real-world data has added further weight to the potential public health benefits of mass-vaccination against the coronavirus.
No evidence that recent blood clot deaths were linked to COVID vaccine The TGA has confirmed there is ‘no likely association’ between the deaths of two NSW men and the AstraZeneca vaccine.